Health and FitnessHealth and Fitness
Wed, July 4, 2012
[ Wed, Jul 04th 2012 ] - Market Wire
Closing of a Private Placement
[ Wed, Jul 04th 2012 ] - Market Wire
Form 8.3 - KEWILL Plc
[ Wed, Jul 04th 2012 ] - Market Wire
Warnex Announces Refinancing
Tue, July 3, 2012
[ Tue, Jul 03rd 2012 ] - Market Wire
AirIQ Settles Legal Claim
[ Tue, Jul 03rd 2012 ] - Market Wire
August 2, 2012

August 2, 2012


Published on 2012-07-03 13:06:48, Last Modified on 2012-07-03 13:29:12 - Market Wire
  Print publication without navigation


Haemonetics Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August... -- BRAINTREE, Mass., July 3, 2012 /PRNewswire/ --

Haemonetics Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August 2, 2012

[ ]
[ ]

BRAINTREE, Mass., July 3, 2012 /PRNewswire/ -- Haemonetics Corporation (NYSE: [ HAE ]) will announce its earnings for the first quarter of its 2013 fiscal year on August 2, 2012 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EDT) on August 2, 2012.

(Logo:  [ http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ] )

Webcast Link: [ http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4802047 ]

Webcast replay will be available from August 2, 2012 after 11:00 am (EDT) until August 9, 2012.

Haemonetics (NYSE: [ HAE ]) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at [ http://www.haemonetics.com ].

CONTACT: Gerry Gould, VP-Investor Relations Tel. (781) 356-9402 [ gerry.gould@haemonetics.com ] Alt. (781) 356-9613  

 

 

 

SOURCE Haemonetics Corporation

[ Back to top ]

RELATED LINKS
[ http://www.haemonetics.com ]